UFP Technologies
UFPT
Market cap $1.8B

233.00 USD

-4.27

1.80%

At close Jun 13, 4:00 PM EDT

After hours

233.00

+0.00

0.00%

1 day

-1.80%

5 days

-2.19%

1 month

-5.97%

3 months

11.15%

6 months

-9.91%

Year to date

-5.37%

1 year

-8.98%

5 years

428.58%

10 years

1,063.26%

About: UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Employees: 4,335

Healthcare Medical Devices

0

Funds holding %

of 7,296 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

30% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 27

6.99% more ownership

Funds ownership: 101.06% [Q4 2024] → 108.05% (+6.99%) [Q1 2025]

4% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 99

0% more funds holding

Funds holding: 277 [Q4 2024] → 278 (+1) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q4 2024] → 4 (+0) [Q1 2025]

12% less capital invested

Capital invested by funds: $1.89B [Q4 2024] → $1.67B (-$219M) [Q1 2025]

82% less call options, than puts

Call options by funds: $1.04M | Put options by funds: $5.66M

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for UFPT.

See Analyst Rankings

Financial journalist opinion

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference

NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Sr. Vice President & CFO, will present at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025. UFP's fireside chat is scheduled to begin at 11:20 AM ET.

UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference

Zacks Investment Research

Is UFP (UFPT) a Solid Growth Stock? 3 Reasons to Think "Yes"

UFP (UFPT) could produce exceptional returns because of its solid growth attributes.

Is UFP (UFPT) a Solid Growth Stock? 3 Reasons to Think "Yes"

UFP Technologies: A Steady Performer

UFP Technologies has shown strong growth through M&A and organic growth, with a defensive business model in an uncertain economy, making it an appealing investment. The company reported a solid first quarter with a 41% sales increase, despite a slowdown in organic growth due to one-offs and inventory de-stocking. Trading at 21-22 times earnings with manageable leverage, UFP has room for further M&A, enhancing its growth prospects and making shares attractive.

UFP Technologies: A Steady Performer

UFP Technologies, Inc. (UFPT) Q1 2025 Earnings Call Transcript

UFP Technologies, Inc. (NASDAQ:UFPT ) Q1 2025 Earnings Conference Call May 6, 2025 10:00 AM ET Company Participants Ron Lataille - Chief Financial Officer Jeff Bailly - Chief Executive Officer & Chairman Conference Call Participants Jaeson Schmidt - Lake Street Brett Fishbin - KeyBanc Justin Ages - CJS Securities Andrew Cooper - Raymond James Operator Good day, and welcome to the UFP Technologies First Quarter of 2025 Earnings Call. All participants will be in a listen-only mode.

UFP Technologies, Inc. (UFPT) Q1 2025 Earnings Call Transcript

UFP Technologies Announces Record Q1 Results

NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024.

UFP Technologies Announces Record Q1 Results

UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open.

UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum

NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18, 2025. UFP's presentation is scheduled to begin at 10:30 AM ET.

UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum

UFP Technologies Announces Record 2024 Results

NEWBURYPORT, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported 2024 net income of $59.0 million, 31.3% higher than net income of $44.9 million for 2023. Adjusted net income grew 32.5% to $67.6 million. Net sales for 2024 were $504.4 million, 26.1% higher than 2023 sales of $400.1 million. GAAP and adjusted earnings per diluted common share outstanding (EPS) were $7.58 and $8.68 respectively.

UFP Technologies Announces Record 2024 Results

UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th.

UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

The Motley Fool

Meet the Little-Known Growth Stock I'm Buying Hand Over Fist in 2025 After a Recent Dip in Price

UFP Technologies (UFPT -0.47%) has seen its share price grow by 12,040% over the last 25 years, making it a 121-bagger. Had investors held their shares throughout that time, they would have turned a $10,000 investment into more than $1.2 million.

Meet the Little-Known Growth Stock I'm Buying Hand Over Fist in 2025 After a Recent Dip in Price

See News Rankings

Charts implemented using Lightweight Charts™